BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18689300)

  • 1. Incidence of haemolytic disease of the newborn in Harare, Zimbabwe.
    Mandisodza AR; Mangoyi G; Musekiwa Z; Mvere D; Abayomi A
    West Afr J Med; 2008 Jan; 27(1):29-31. PubMed ID: 18689300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual case of ABO-haemolytic disease of the newborn.
    Haque KM; Rahman M
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of positive direct antiglobulin tests found on cord blood sampling.
    Dinesh D
    J Paediatr Child Health; 2005; 41(9-10):504-7. PubMed ID: 16150068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of ABO haemolytic disease of the newborn at Kenyatta National Hospital Nairobi, 1977.
    Kinoti SN; Kimemiah SG; Hutcheon RA
    East Afr Med J; 1979 Mar; 56(3):127-33. PubMed ID: 487977
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of C1q in Rhesus haemolytic disease of the newborn.
    Poorkhorsandi ME; Gupte SC
    Indian J Med Res; 1996 Sep; 104():208-12. PubMed ID: 8898479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is antenatal antibody screening worthwhile in the Zimbabwean population?
    Cakana AZ; Ngwenya L
    Cent Afr J Med; 2000 Feb; 46(2):38-41. PubMed ID: 14674207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional study of haemolytic disease of the newborn in Uganda.
    Dhabangi A; Nankunda J; Okaba V; Nakubulwa S; Hume HA; Dzik WH; Heddle NM
    Vox Sang; 2022 Dec; 117(12):1398-1404. PubMed ID: 36342344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemolytic disease of the newborn in Western Australia 1974 to 1976.
    Vieira BI; Murdock CJ; Hendry PJ; Stanley F; Davey MG
    Aust N Z J Obstet Gynaecol; 1980 May; 20(2):69-72. PubMed ID: 6774705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
    Craig S; Morris K; Tubman T; McClure B
    Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug prescribing in paediatric in-patients at Harare and Parirenyatwa Central Hospitals.
    Nhachi CF; Kasilo OM; Nathoo S
    Cent Afr J Med; 1992 Feb; 38(2):57-62. PubMed ID: 1505010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO-haemolytic disease of the newborn (ABO-HDN): factors influencing its severity and incidence in Venezuela.
    Cariani L; Romano EL; Martínez N; Montaño R; Suarez G; Ruiz I; Soyano A
    J Trop Pediatr; 1995 Feb; 41(1):14-21. PubMed ID: 7723123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of red cells preserved in extended storage media for exchange transfusion in anti-k haemolytic disease of the newborn.
    Win N; Amess P; Needs M; Hewitt PE
    Transfus Med; 2005 Apr; 15(2):157-60. PubMed ID: 15859984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune cytopenias in newborns].
    Brossard Y
    Rev Prat; 2001 Sep; 51(14):1571-6. PubMed ID: 11757274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990.
    Hughes RG; Craig JI; Murphy WG; Greer IA
    Br J Obstet Gynaecol; 1994 Apr; 101(4):297-300. PubMed ID: 8199074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rate of and indications for enucleations at Sekuru Kaguvi Eye Unit in Harare: a comparative analysis.
    Epee E; Masanganise R
    Cent Afr J Med; 2003; 49(1-2):13-5. PubMed ID: 14562595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody dependent cell mediated cytotoxicity and erythrophagocytosis assays in Rh haemolytic disease of the newborn.
    Patil JS; Gupte SC
    Ceylon Med J; 1996 Jun; 41(2):46-50. PubMed ID: 8771942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two years' experience with Rh hemolytic disease reporting.
    Hawes WE; Mordaunt VL
    Calif Med; 1973 May; 118(5):28-32. PubMed ID: 4633598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.